NCT01160796View on ClinicalTrials.gov

Lcr35® for Bacterial Vaginosis Prevention

PHASE3CompletedINTERVENTIONAL
Enrollment

352

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

April 30, 2012

Conditions
Bacterial Vaginosis
Interventions
DRUG

placebo

1x14-day course of treatment during 4 cycles

DRUG

Lcr35®

1x14-day course of treatment during 4 cycles

Trial Locations (1)

15000

Lyocentre, Aurillac

Sponsors
All Listed Sponsors
lead

Laboratoires Lyocentre

INDUSTRY

NCT01160796 - Lcr35® for Bacterial Vaginosis Prevention | Biotech Hunter | Biotech Hunter